Drug shortage
Amlodipine Besylate; Hydrochlorothiazide; Olmesartan Medoxomil Tablet · Torrent Pharma Inc.
FDA drug shortage · To Be Discontinued · updated Jun 13, 2025
Key facts
| Generic name | Amlodipine Besylate; Hydrochlorothiazide; Olmesartan Medoxomil Tablet |
|---|---|
| Company | Torrent Pharma Inc. |
| Presentation | Amlodipine Besylate; Hydrochlorothiazide; Olmesartan Medoxomil, Tablet, 5 mg; 25 mg; 40 mg (NDC 13668-385-90) |
| Dosage form | Tablet |
| Status | To Be Discontinued |
| Therapeutic category | Cardiovascular |
| Package NDCs | 13668-385-90 |
| First posted | Jun 13, 2025 |
| Last updated | Jun 13, 2025 |
| Discontinued | Jun 13, 2025 |
At a glance
- 1–9 Package NDCs affected
- 10–99 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: